Latest Memorial Sloan–Kettering Cancer Center Stories
Health experts recommend that people of all ages use sunscreens regularly to prevent skin cancer; yet, a new study shows that only 25 percent of kids regularly apply sunscreen when going outside in the sun.
CHICAGO, July 29, 2011 /PRNewswire/ -- Errant Gene Therapeutics, LLC ("EGT"), a pioneering boutique drug development firm specializing in Rare Diseases, announced the transfer of its clinical grade lentiviral vector, TNS 9.55.3, to Memorial Sloan Kettering Cancer Center ("MSKCC").
Worldâ€™s Largest Private Cancer Center to Expand Device Connectivity Efforts. Panama City, FL (PRWEB) July 25, 2011 iSirona®, a provider of simplified solutions for medical device integration, today announced that Memorial Sloan-Kettering Cancer Center has signed an enterprise license agreement to implement iSironaâ€™s device connectivity solution.
WASHINGTON, July 25, 2011 /PRNewswire-USNewswire/ -- LUNGevity Foundation and GRACE are pleased to partner in providing an upcoming one-hour webinar on Wednesday, July 27th at 6 p.m. Eastern/3 p.m.